| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kiromic BioPharma Inc (NASDAQ: KRBP)
KRBP Technical Analysis
5
| As on 21st Mar 2025 KRBP STOCK Price closed @ 0.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.72 & Strong Sell for SHORT-TERM with Stoploss of 2.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KRBPSTOCK Price
| Open | 0.74 | Change | Price | % |
| High | 0.74 | 1 Day | -0.66 | -68.75 |
| Low | 0.30 | 1 Week | -1.01 | -77.10 |
| Close | 0.30 | 1 Month | -0.70 | -70.00 |
| Volume | 98399 | 1 Year | -2.40 | -88.89 |
| 52 Week High 3.46 | 52 Week Low 0.18 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 117.70 | -0.70% |
| RNAZ | 1.12 | 45.45% |
| TSLA | 248.71 | 5.27% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| HBAN | 15.02 | 0.47% |
| LCID | 2.42 | 6.14% |
| INTC | 24.26 | 1.25% |
| AAPL | 218.27 | 1.95% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KRBP Daily Charts |
KRBP Intraday Charts |
Whats New @ Bazaartrend |
KRBP Free Analysis |
|
|
KRBP Important Levels Intraday
| RESISTANCE | 1.15 |
| RESISTANCE | 0.88 |
| RESISTANCE | 0.71 |
| RESISTANCE | 0.54 |
| SUPPORT | 0.06 |
| SUPPORT | -0.11 |
| SUPPORT | -0.28 |
| SUPPORT | -0.55 |
KRBP Forecast March 2025
| 4th UP Forecast | 2.5 |
| 3rd UP Forecast | 1.79 |
| 2nd UP Forecast | 1.36 |
| 1st UP Forecast | 0.92 |
| 1st DOWN Forecast | -0.32 |
| 2nd DOWN Forecast | -0.76 |
| 3rd DOWN Forecast | -1.19 |
| 4th DOWN Forecast | -1.9 |
KRBP Weekly Forecast
| 4th UP Forecast | 1.61 |
| 3rd UP Forecast | 1.19 |
| 2nd UP Forecast | 0.93 |
| 1st UP Forecast | 0.67 |
| 1st DOWN Forecast | -0.07 |
| 2nd DOWN Forecast | -0.33 |
| 3rd DOWN Forecast | -0.59 |
| 4th DOWN Forecast | -1.01 |
KRBP Forecast2025
| 4th UP Forecast | 7.85 |
| 3rd UP Forecast | 5.43 |
| 2nd UP Forecast | 3.93 |
| 1st UP Forecast | 2.44 |
| 1st DOWN Forecast | -1.84 |
| 2nd DOWN Forecast | -3.33 |
| 3rd DOWN Forecast | -4.83 |
| 4th DOWN Forecast | -7.25 |
Kiromic BioPharma Inc ( NASDAQ USA Symbol : KRBP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KRBP Business Profile
Kiromic BioPharma, Inc., a target discovery and gene editing company, focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1; and chimeric gamma delta PD1 T cell switch receptor therapy. It has license agreements with Mercer University; CGA 369 Intellectual Holdings, Inc.; and Longwood University, as well as research and development collaboration agreements with Molipharma, S.R.L. and Leon Office (H.K.). The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. Address: 7707 Fannin, Houston, TX, United States, 77054
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service